Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Astellas - The maturing treatment landscape of mHSPC

Q&A

Date

11 Sep 2022

Session

Astellas - The maturing treatment landscape of mHSPC

Topics

Tumour Site

Prostate Cancer

Presenters

Shahrokh F. Shariat

Authors

S. Oudard1, I.D. Davis2, H. Payne3, S.F. Shariat4

Author affiliations

  • 1 Immunotherapy Dept, HEGP - Hopital Europeen Georges-Pompidou - AP-HP, 75015 - Paris/FR
  • 2 Eastern Health Clinical School - Monash University, 3128 - Box Hill/AU
  • 3 UCLH Foundation Trust, London/GB
  • 4 Urology Department, MedUni Wien - Medical University of Vienna, 1090 - Vienna/AT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Stephane Oudard

Session: Astellas - The maturing treatment landscape of mHSPC

Resources:

Webcast

Closing remarks

Presenter: Stephane Oudard

Session: Astellas - The maturing treatment landscape of mHSPC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.